<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE325nnn/GSE325970/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE325970</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Glypican-1 upregulation elicited in response to a cell-impermeable kinase inhibitor and its overexpression enhance HIV infection</name><description>Studies of herpes simplex virus (HSV) entry revealed a previously unrecognized "outside-in" signaling pathway involving phosphatidylserine (PS) scrambling and associated translocation and subsequent extracellular activation of canonical intracellular proteins, including Akt. We hypothesized that HIV-1, which activates a different scramblase, TMEM16F, to induce PS externalization, may similarly trigger an "outside-in" signaling response to promote viral entry. To study this process, we utilized a cell-impermeable staurosporine analog, alkyl-CIMSS, which is a broadly active kinase inhibitor that blocks HSV-induced exofacial Akt phosphorylation, and HSV entry. We show that TMEM16F-mediated PS externalization in response to HIV is not associated with Akt translocation; however, surprisingly, pretreatment of cells with alkyl-CIMSS enhanced HIV-1 infection post-entry. To identify potential biological processes that mediated this enhancement, we performed whole-cell total and phosphoproteomics, and bulk RNA sequencing. Cells treated with alkyl-CIMSS exhibited increased cyclin-dependent kinase (CDK) activity, resulting in higher levels of phosphorylated SAMHD1. Further, alkyl-CIMSS treatment robustly upregulated the cell surface density of the proteoglycan glypican-1 (GPC1). Lentivirus-driven GPC1 overexpression or shRNA knockdown demonstrated that, independent of alkyl-CIMSS treatment, GPC1 expression promotes HIV infection. Collectively, these findings demonstrate that alkyl-CIMSS modulates the exofacial plasma membrane to promote susceptibility to HIV infection by increasing CDK activity and upregulating GPC1.</description><dates><publication>2026/04/01</publication></dates><accession>GSE325970</accession><cross_references><GSM>GSM9618168</GSM><GSM>GSM9618169</GSM><GSM>GSM9618177</GSM><GSM>GSM9618178</GSM><GSM>GSM9618175</GSM><GSM>GSM9618176</GSM><GSM>GSM9618173</GSM><GSM>GSM9618174</GSM><GSM>GSM9618171</GSM><GSM>GSM9618172</GSM><GSM>GSM9618170</GSM><GPL>34281</GPL><GSE>325970</GSE><taxon>Homo sapiens</taxon><PMID>[42112903]</PMID></cross_references></HashMap>